Accuray

Accuray is a radiation therapy company that develops, manufactures, and sells radiation therapy systems to deliver treatments including stereotactic radiosurgery (SRS) and stereotactic body radiation therapy (SBRT).

VP, Global Business Excellence & PMO

CamAlex Castle Consulting (Founder)

Providing expertise to the Biopharma and Med. Tech. industry with focused experience in research and development (R&D), translating strategy into operational success and sustainable growth.  Areas of expertise include:
Portfolio and Project Management | Strategic and Tactical Planning and Execution | Financial Operations | Clinical Operations | Resource Management |  Business Intelligence and Analytics |  Change Management | System Development | People and Space Planning | Team Building | Leadership, and Mentoring | Process Improvement

Bio-Pharma Consultant

Enzyvant

At Enzyvant I led a team of project managers across both development and commercial phase assets. I guided the creation, analysis and refinement of drug development and post-approval strategies for multiple programs at both the portfolio and project deliverable level. I brought unique expertise to identify the most efficient path to success with focus on performance and accountability to accelerate delivery against objectives with streamlined resources and the highest quality.

VP, Head of Program & Portfolio Management, Enzyvant

FlowMetric Life Sciences

Served on leadership team for niche Contract Research Organization with 50 employees globally.
Held accountable for P&L and ROI and for all aspects of global launch of a novel, patented global diagnostics platform. 
Developed strategic plan and secured funding from several investors in first 3 months. Launched within 6 months with best-in-class partners and vendors, platform website and digital portal to support e-commerce, robust supply chain and associated logistics. Expanded revenue streams and return on investment >10X through unique pathway and partnerships that further enhanced launch plan. Mapped successful regulatory path for multi-channel launch. Achieved revenues > $400M in first six months of launch. Left FlowMetric after it was purchased by KCAS and product was removed from portfolio.

Executive Vice President and General Manager of FlowMetric Life Sciences

Head of portfolio planning, R&D finance, systems and analytics. In this broad role I had accountability for R&D operations including leading the project management function and  ownership of the R&D annual budget incorporating financial management best practices and oversight. Specifically, I was accountable for the management of the overall R&D portfolio of projects including ensuring maintenance of the budget in line with agreed targets while ensuring delivery against R&D Corporate milestones. Since leading R&D finance R&D achieved an actual to budget full year variance of <5% for 3 consecutive years
In addition I was focused on developing the processes, systems and analytics to facilitate best in class portfolio management to maximize return on investment for the company. 
This was achieved by building upon strong Development practices and Commercial acumen to realize a robust pipeline of high value products for future growth across all areas of the company. 

Key Accomplishments include:
- introduced portfolio planning across entire project line including identification of portfolio value drivers in mid to long term 
- reduced R&D spend vs. budget variance from >10% to <2% in 3 three years
- revamped performance setting resulting in development milestone attainment improving 35% 
- centralized tracking and reporting of clinical studies across all business units

Senior Vice President and Head of Portfolio Planning, Systems & Analytics

Allergan

Site head of the Bridgewater Allergan R&D location with regional responsibility for all local Development operations. I was also head of Global R&D Resource Planning, Business Analytics and R&D Systems group within the Business Strategy Function.
Responsibilities include:
- Site Head; Bridgewater - R&D Allergan
- Regional Development Head of Operations with 14 direct and greater than 100 indirect reports
- Oversaw the R&D Portfolio Budget ($1B annual budget)
- Led clinical resource planning using objective resource analytics across clinical operations. 

Other experience at Allergan: Submitted >10 INDs including both small molecule and biologic entities. Project management background across all phases of Development including submission and post marketing commitments.

Sr. Director & Head - Business Analytics, Capacity Planning & Systems & Site Head of AGN Bridgewater

Responsible for both project management of two Development projects and leader of R&D metrics, productivity and clinical resource management

Director, Analysis Group; Global Project & Portfolio Management

Experienced life sciences senior leader with proven record of successful operational delivery and value creation. 

Focus: Leading strategy and operations including project & program management, portfolio optimization & planning, finance, clinical operations, capacity planning, productivity & performance management  

Ph.D. (immunology / pathogenic microbiology) trained professional with more than 20 years of biopharma, medical technology and diagnostics industry experience

Taplio

Grant Morgan's Linkedin Analytics

Grant Morgan

Want to drive more opportunities from LinkedIn?

Taplio

.css-1jgreyo{background-image:linear-gradient(284deg, rgba(39,43,72,1) 0%, rgba(33,47,183,1) 100%);color:transparent;-webkit-background-clip:text;background-clip:text;}Grant Morgan's Linkedin Analytics

Grant Morgan

Want to drive more opportunities from LinkedIn?

Grant Morgan's Linkedin Analytics